Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- WAFD -6.3%, UAL -5%, IBKR -3.3%, SCL -3.3%, JBHT -3.1%, ASML -3.1%, CFG -3%, CBSH -2.7%, MS -2.3%, WGO -1.8%, ALLY -1.6%, PNFP -1.1%
Other news:
- BAER -6.2% (commences $70 mln public offering)
- MIRM -5.9% (FDA extends review of sNDA for LIVMARLI)
- RARE -5.1% (commences $300 mln stock offering)
- BIO -4.7% (CFO to resign)
- GOGO -4.6% (selected by AirSprint Private Aviation for upgrade)
- LXRX -4% (highlights upcoming presentations of two studies re financial impact of INPEFA)
- TEX -3.2% (CEO to retire; names new CEO raises FY23 outlook)
- SGHT -3.2% (10% workforce reduction)
- ANTX -2% (received an exclusive license from the University of Georgia Research Foundation to advance the development of a boron-containing small molecule for Chagas disease)
- YMAB -1.9% (FDA clears IND application for CD38-SADA)
- LECO -1.8% (increases dividend)
- THS -1.7% (SJM to sell four brands to THS for $20 mln)
- AMAM -1.5% (files $300 mln mixed shelf securities offering)
- AAL -1.5% (in sympathy with UAL earnings)
- DAL -1.3% (in sympathy with UAL earnings)
- ALK -1.3% (in sympathy with UAL earnings)
- NVDA -1.3% (disclosed last night it does not anticipate that the additional restrictions will have a near-term meaningful impact on its financial results)
- BHP -1.3% (Q3 production)
- TAK -1.1% (settles tax dispute with Irish Revenue over break fee received by Shire) .
Analyst comments:
- LAC -3.3% (downgraded to Hold from Buy at Deutsche Bank)
- SQM -3.3% (owngraded to Underperform from Neutral at BofA Securities)
- MT -3% (downgraded to Neutral from Buy at BofA Securities)
- SHW -2.4% (downgraded to Underperform from Neutral at BofA Securities)
- ALB -2.2% (downgraded to Underperform from Neutral at BofA Securities)